| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |